Clinical characteristics of 2019 novel coronavirus pneumonia in Zhejiang province, China
Since December 2019, an increasing number of cases associated with the 2019 novel coronavirus (2019‑nCoV) have emerged in Wuhan, China, which has resulted in a rapid outbreak in China and worldwide. The present study aimed to describe the clinical, laboratory and radiological characteristics of 2019‑nCoV pneumonia (NCP) in Zhejiang province, outside of Wuhan. A total of 74 patients with 2019‑nCoV were continuously enrolled between January 22 and March 2, 2020 at Zhejiang Hospital. Diagnosis was confirmed at Zhejiang Hospital by reverse transcription‑PCR (RT‑PCR), which was approved by the Chinese government. Subsequently, the clinical features between positive‑ and negative‑NCP patients in Zhejiang were compared. Among the 74 hospitalized patients with suspected 2019‑NCP, six patients (one male and five female patients) were confirmed to be infected with 2019‑nCoV by RT‑PCR. The average age of the confirmed patients was 40±13 years. There were three family clusters among the confirmed cases, one patient from each of these families had travel history or contact with patients from Wuhan within 2 weeks. Compared with non‑NCP patients, the most common symptoms at onset for patients with NCP were fever (5/6; 83.3%) and cough (5/6; 83.3%), followed by dyspnea/pharyngalgia (2/6; 33.3%), whereas myalgia (1/6; 16.7%) and fatigue (1/6; 16.7%) were less common. All 74 patients with suspected NCP exhibited abnormal computerized tomography (CT) images. In total, 2/6 (33.3%) patients with confirmed NCP presented with bilateral pneumonia, and 21/68 (30.9%) non‑NCP patients exhibited bilateral pneumonia, with bilateral distribution of patchy shadows or ground glass opacity. The present study revealed that epidemiological history was critical to the diagnosis of 2019‑nCoV in low epidemic regions outside Hubei province. It was also identified that chest CT could not replace nucleic acid testing due to similar radiological manifestations.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Molecular medicine reports - 22(2020), 3 vom: 01. Sept., Seite 2583-2587 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chen, Ling [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2019 novel coronavirus pneumonia |
|---|
| Anmerkungen: |
Date Completed 04.08.2020 Date Revised 29.09.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3892/mmr.2020.11329 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM312812132 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM312812132 | ||
| 003 | DE-627 | ||
| 005 | 20231225145222.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3892/mmr.2020.11329 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1042.xml |
| 035 | |a (DE-627)NLM312812132 | ||
| 035 | |a (NLM)32705222 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chen, Ling |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical characteristics of 2019 novel coronavirus pneumonia in Zhejiang province, China |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.08.2020 | ||
| 500 | |a Date Revised 29.09.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Since December 2019, an increasing number of cases associated with the 2019 novel coronavirus (2019‑nCoV) have emerged in Wuhan, China, which has resulted in a rapid outbreak in China and worldwide. The present study aimed to describe the clinical, laboratory and radiological characteristics of 2019‑nCoV pneumonia (NCP) in Zhejiang province, outside of Wuhan. A total of 74 patients with 2019‑nCoV were continuously enrolled between January 22 and March 2, 2020 at Zhejiang Hospital. Diagnosis was confirmed at Zhejiang Hospital by reverse transcription‑PCR (RT‑PCR), which was approved by the Chinese government. Subsequently, the clinical features between positive‑ and negative‑NCP patients in Zhejiang were compared. Among the 74 hospitalized patients with suspected 2019‑NCP, six patients (one male and five female patients) were confirmed to be infected with 2019‑nCoV by RT‑PCR. The average age of the confirmed patients was 40±13 years. There were three family clusters among the confirmed cases, one patient from each of these families had travel history or contact with patients from Wuhan within 2 weeks. Compared with non‑NCP patients, the most common symptoms at onset for patients with NCP were fever (5/6; 83.3%) and cough (5/6; 83.3%), followed by dyspnea/pharyngalgia (2/6; 33.3%), whereas myalgia (1/6; 16.7%) and fatigue (1/6; 16.7%) were less common. All 74 patients with suspected NCP exhibited abnormal computerized tomography (CT) images. In total, 2/6 (33.3%) patients with confirmed NCP presented with bilateral pneumonia, and 21/68 (30.9%) non‑NCP patients exhibited bilateral pneumonia, with bilateral distribution of patchy shadows or ground glass opacity. The present study revealed that epidemiological history was critical to the diagnosis of 2019‑nCoV in low epidemic regions outside Hubei province. It was also identified that chest CT could not replace nucleic acid testing due to similar radiological manifestations | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a 2019 novel coronavirus pneumonia | |
| 650 | 4 | |a epidemiological history | |
| 650 | 4 | |a reverse transcription-Pcr | |
| 700 | 1 | |a Jin, Qiuhong |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Jiao |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Zhehua |e verfasserin |4 aut | |
| 700 | 1 | |a Ge, Ke |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Jiangle |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Hong |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular medicine reports |d 2008 |g 22(2020), 3 vom: 01. Sept., Seite 2583-2587 |w (DE-627)NLM192195727 |x 1791-3004 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2020 |g number:3 |g day:01 |g month:09 |g pages:2583-2587 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3892/mmr.2020.11329 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2020 |e 3 |b 01 |c 09 |h 2583-2587 | ||